Joseph Garfield Crompton

Joseph Crompton practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Joseph Crompton's NPI, 1568649549, was assigned on January 22, 2008. Joseph Crompton graduated from The Johns Hopkins University School of Medicine in 2009. Joseph Crompton holds California license A117302.

Joseph Crompton's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Joseph Crompton's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Joseph Crompton is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Surgical Oncology Associates. Dmand AI also links Joseph Crompton to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Joseph Crompton practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Joseph Crompton's primary specialty in the NPI Registry, under taxonomy code 208600000X. Joseph Crompton is board certified in complex general surgical oncology by the American Board of Surgery. Dmand AI has Joseph Crompton's licenses on file in 3 states: California, New York and Maryland.

CMS data shows 174 Medicare services from Joseph Crompton across 6 procedure codes in 2024, for 104 Medicare patients. Medicare paid $28,564 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 104 Medicare patients who saw Joseph Crompton in 2026. The largest group is 65 to 74, with 47 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Joseph Crompton's median patient age at 66, with 44% women.

In 2026, Joseph Crompton wrote 24 Medicare Part D claims for 15 patients. 100% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $64 in total drug cost. In 2017, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Joseph Crompton for performance year 2026, reported as part of a group. Joseph Crompton accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Joseph Crompton as offering telehealth. CMS counts 43 procedures of melanoma (skin cancer) excision by Joseph Crompton, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 26 papers to Joseph Crompton, published from 2010 to 2021. 2015 was the busiest year, with 7. Joseph Crompton's most frequent co-authors are David Cameron Clever, MD, Pawel Juliusz Muranski, MD and Matthias Richard Benz, MD.

CMS Open Payments shows 1 general payment to Joseph Crompton from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Intuitive Surgical, Inc. paid the most, $124.

Dmand AI lists 1 award for Joseph Crompton.

Joseph Crompton graduated from The Johns Hopkins University School of Medicine in 2009. Joseph Crompton is a member of ACS.

Joseph Crompton is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.